These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24480636)

  • 1. Clinical and economic outcomes in medication-adherent and -nonadherent patients with type 2 diabetes mellitus in the Republic of Korea.
    An SY; Kim HJ; Chun KH; Kim TH; Jeon JY; Kim DJ; Han SJ; Kim YS; Woo JT; Ahn KJ; Park Y; Nam M; Baik SH; Lee KW
    Clin Ther; 2014 Feb; 36(2):245-54. PubMed ID: 24480636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of Change in Adherence Status from 1 Year to the Next Among Patients with Type 2 Diabetes Mellitus on Oral Antidiabetes Drugs.
    Saundankar V; Peng X; Fu H; Ascher-Svanum H; Rodriguez A; Ali A; Slabaugh L; Young P; Louder A
    J Manag Care Spec Pharm; 2016 May; 22(5):467-82. PubMed ID: 27123910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Association Between Adherence to Insulin Therapy and Health Care Costs for Adults with Type 2 Diabetes: Evidence from a U.S. Retrospective Claims Database.
    Eby EL; Bajpai S; Faries DE; Haynes VS; Lage MJ
    J Manag Care Spec Pharm; 2020 Sep; 26(9):1081-1089. PubMed ID: 32857656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of Medication Adherence with Hospital Utilization and Costs Among Elderly with Diabetes Enrolled in a State Pharmaceutical Assistance Program.
    Pednekar P; Heller DA; Peterson AM
    J Manag Care Spec Pharm; 2020 Sep; 26(9):1099-1108. PubMed ID: 32857648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and economic outcomes among patients with diabetes mellitus initiating insulin glargine pen versus vial.
    Grabner M; Chu J; Raparla S; Quimbo R; Zhou S; Conoshenti J
    Postgrad Med; 2013 May; 125(3):204-13. PubMed ID: 23748521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of medication adherence and persistence on clinical and economic outcomes in patients with type 2 diabetes treated with liraglutide: a retrospective cohort study.
    Buysman EK; Liu F; Hammer M; Langer J
    Adv Ther; 2015 Apr; 32(4):341-55. PubMed ID: 25832470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication regimen complexity and its impact on medication adherence and glycemic control among patients with type 2 diabetes mellitus in an Ethiopian general hospital.
    Ayele AA; Tegegn HG; Ayele TA; Ayalew MB
    BMJ Open Diabetes Res Care; 2019; 7(1):e000685. PubMed ID: 31321061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economic rationale for adherence in the treatment of type 2 diabetes mellitus.
    Wild H
    Am J Manag Care; 2012 Apr; 18(3 Suppl):S43-8. PubMed ID: 22558941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to Oral Glucose-Lowering Therapies and Associations With 1-Year HbA1c: A Retrospective Cohort Analysis in a Large Primary Care Database.
    Farmer AJ; Rodgers LR; Lonergan M; Shields B; Weedon MN; Donnelly L; Holman RR; Pearson ER; Hattersley AT
    Diabetes Care; 2016 Feb; 39(2):258-263. PubMed ID: 26681714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective Study on the Impact of Adherence in Achieving Glycemic Goals in Type 2 Diabetes Mellitus Patients Receiving Canagliflozin.
    Buysman EK; Anderson A; Bacchus S; Ingham M
    Adv Ther; 2017 Apr; 34(4):937-953. PubMed ID: 28251556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of self-monitoring of blood glucose use with medication adherence and glycemic control in patients with type 2 diabetes initiating non-insulin treatment.
    Virdi N; Daskiran M; Nigam S; Kozma C; Raja P
    Diabetes Technol Ther; 2012 Sep; 14(9):790-8. PubMed ID: 22775240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to Guidelines for Inpatient Pharmacologic Management of Type 2 Diabetes in Adults and Glycemic Outcomes.
    Alkhiari R; Alzayer H; Aljazeeri J; Vanniyasingam T; Punthakee Z
    Can J Diabetes; 2018 Apr; 42(2):158-162. PubMed ID: 28662968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication Management Program: Adherence, Disease-related Knowledge, Health-related Quality of Life, and Glycemic Control for Type 2 Diabetes Mellitus.
    Nazir SUR; Hassali MA; Saleem F; Haque N
    Altern Ther Health Med; 2020 Jul; 26(S2):4-10. PubMed ID: 31634877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder.
    Vega C; Becker RV; Mucha L; Lorenz BH; Eaddy MT; Ogbonnaya AO
    Curr Med Res Opin; 2017 Oct; 33(10):1879-1889. PubMed ID: 28644095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health and economic outcomes for exenatide once weekly, insulin, and pioglitazone therapies in the treatment of type 2 diabetes: a simulation analysis.
    Gaebler JA; Soto-Campos G; Alperin P; Cohen M; Blickensderfer A; Wintle M; Maggs D; Hoogwerf B; Han J; Pencek R; Peskin B
    Vasc Health Risk Manag; 2012; 8():255-64. PubMed ID: 22566747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Direct health care costs in patients with type 2 diabetes mellitus six months after starting insulin treatment in Spain: the INSTIGATE study].
    Costi M; Smith H; Reviriego J; Castell C; Goday A; Dilla T
    Endocrinol Nutr; 2011; 58(6):274-82. PubMed ID: 21641287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of diabetes control on mortality by race in a national cohort of veterans.
    Hunt KJ; Gebregziabher M; Lynch CP; Echols C; Mauldin PD; Egede LE
    Ann Epidemiol; 2013 Feb; 23(2):74-9. PubMed ID: 23238350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of adherence and insulin delivery system on clinical and economic outcomes among patients with type 2 diabetes initiating insulin treatment.
    Ayyagari R; Wei W; Cheng D; Pan C; Signorovitch J; Wu EQ
    Value Health; 2015 Mar; 18(2):198-205. PubMed ID: 25773555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of initiating insulin glargine disposable pen versus vial/syringe on real-world glycemic outcomes and persistence among patients with type 2 diabetes mellitus in a large managed care plan: a claims database analysis.
    Xie L; Zhou S; Pinsky BW; Buysman EK; Baser O
    Diabetes Technol Ther; 2014 Sep; 16(9):567-75. PubMed ID: 24735083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A cross-sectional study clarifying profiles of patients with diabetes who discontinued pharmacotherapy: reasons and consequences.
    Tominaga Y; Morisky DE; Mochizuki M
    BMC Endocr Disord; 2021 Jun; 21(1):117. PubMed ID: 34120602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.